These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 28450715)
1. Thomas Lynch. Nat Rev Drug Discov; 2017 Apr; 16(5):308. PubMed ID: 28450715 [No Abstract] [Full Text] [Related]
2. [The current potentials and outlook for drug therapy in oncology]. Gershanovich ML; Borisov VI; Sidorenko IuS; Tiuliandin SA; Gorbunova VA Vopr Onkol; 1995; 41(2):116-24. PubMed ID: 7483406 [No Abstract] [Full Text] [Related]
3. Impact of the human genome on the discovery of immune-modulatory therapeutics. Manning AM Curr Opin Investig Drugs; 2006 May; 7(5):406-11. PubMed ID: 16729715 [No Abstract] [Full Text] [Related]
4. Where next for research and development in oncology? Greatrex J Lancet Oncol; 2011 Mar; 12(3):219-20. PubMed ID: 21495241 [No Abstract] [Full Text] [Related]
5. To all involved - we have a problem. Romero D Nat Rev Clin Oncol; 2018 Jul; 15(7):397. PubMed ID: 29880897 [No Abstract] [Full Text] [Related]
6. Molecular imaging: what picture does it paint for future oncology? Price P; Jones T Drug Discov Today; 2002 Jul; 7(14):741-3. PubMed ID: 12547021 [No Abstract] [Full Text] [Related]
7. Oncology business development global summit. Bockman JM; Nalam S IDrugs; 2005 Jan; 8(1):37-40. PubMed ID: 15650940 [No Abstract] [Full Text] [Related]
14. Vision and will: the future of the FDA. Epstein D Oncologist; 2009 Apr; 14(4):317-9. PubMed ID: 19365098 [No Abstract] [Full Text] [Related]
15. A Multifaceted Battle Against Cancer. Liu X; Reiss C Yale J Biol Med; 2015 Jun; 88(2):105-6. PubMed ID: 26219136 [No Abstract] [Full Text] [Related]
16. [The current trends in the development of new immunobiological preparations]. Vorob'ev AA Zh Mikrobiol Epidemiol Immunobiol; 1999; (5):16-21. PubMed ID: 10852017 [TBL] [Abstract][Full Text] [Related]
17. [From a crisis to another...Pharmaceutical industry--economics]. Scheen AJ Rev Med Liege; 2009 Jan; 64(1):3-5. PubMed ID: 19317093 [No Abstract] [Full Text] [Related]
18. Familial cancer 2003 - research and practice, Couran Cove, Queensland, Australia, 3-6 September 2003. Lindeman GJ Fam Cancer; 2004; 3(1):75-7. PubMed ID: 15131410 [No Abstract] [Full Text] [Related]
19. Molecular pathology in oncology--the AstraZeneca perspective. Campbell DA; Carmichael J; Chopra R Pharmacogenomics; 2004 Dec; 5(8):1167-73. PubMed ID: 15584883 [TBL] [Abstract][Full Text] [Related]
20. [Drug development in oncology. Its status and outlook with special consideration of the position of Germany]. Strohmeyer T; Weissbach L Dtsch Med Wochenschr; 1999 Feb; 124(8):231-5. PubMed ID: 10093574 [No Abstract] [Full Text] [Related] [Next] [New Search]